Exosomes: Next generation medicine
Department of Stem Cells, StemRx Bioscience Solutions Pvt. Ltd, Navi Mumbai, India.
Review Article
World Journal of Advanced Research and Reviews, 2022, 16(01), 102–110
Article DOI: 10.30574/wjarr.2022.16.1.1007
Publication history:
Received on 01 September 2022, revised on 02 October 2022, accepted on 05 October 2022
Abstract:
Extracellular vesicles (EVs) are the substances that are conveyed by most sorts of cell, which play a critical role in cell-to-cell communication. Exosomes are among the most commonly explored EVs. Exosomes contain lipids, RNAs and proteins. Many examinations have shown that exosomes derived from cells play different biological roles in normal as well as diseased condition. Recent investigations have explored exosomes as natural drug delivery vehicles, as they have ability to deliver different cargo to nearby and targeted cells with high specificity and efficiency. In the last decade, there has been increased interest in exosomes research due to their potential role in disease diagnosis as intercellular messengers. Exosomes have potential in targeted drug/gene delivery, due to their unique properties, such as low immunogenicity, excellent tissue/cell penetration capacity and innate stability. As a result, exosomes can be used for disease detection and for various treatments. In this review, we focus on the potential use of exosomes as valuable diagnostic and prognostic biomarkers for their cell-lineage and state-specific contents, and their possible use as therapeutic vehicle for drug and gene delivery. As a drug, exosomes have a variety of applications in various diseases.
Keywords:
Extracellular vesicles; Exosomes; Drug delivery; Cancer
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0